Cromwell Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135K Sell
3,166
-1,299
-29% -$70.5K 0.06% 280
2026
Q1
$280K Hold
4,465
0.16% 127
2025
Q4
$426K Hold
4,465
0.23% 82
2025
Q3
$436K Hold
4,465
0.23% 80
2025
Q2
$480K Hold
4,465
0.29% 62
2025
Q1
$450K Hold
4,465
0.29% 69
2024
Q4
$399K Hold
4,465
0.23% 81
2024
Q3
$374K Hold
4,465
0.24% 84
2024
Q2
$344K Buy
+4,465
New +$327K 0.21% 90

Other funds holding BSX

Cromwell Holdings's BSX Position: Q2 2026 in Review

Cromwell Holdings reduced its Boston Scientific (BSX) stake by 29% in Q2 2026, selling an estimated $70.5K and leaving 3,166 shares worth $135K. The position accounts for 0.06% of the portfolio, ranked #280.

Cromwell Holdings first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $480K in Q2 2025. 292 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cromwell Holdings held 3,166 shares of Boston Scientific worth $135K as of Q2 2026.
  • Cromwell Holdings sold 1,299 Boston Scientific shares in Q2 2026, an estimated $70.5K.
  • Boston Scientific made up 0.06% of Cromwell Holdings's portfolio in Q2 2026, its #280 holding.
  • Cromwell Holdings first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Boston Scientific position peaked at $480K in Q2 2025.
  • 292 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.